EE200900049A - Ethin 1 "Pharmaceutical Composition Containing Stradiol and Drospirenone for Use as a Contraceptive - Google Patents
Ethin 1 "Pharmaceutical Composition Containing Stradiol and Drospirenone for Use as a ContraceptiveInfo
- Publication number
- EE200900049A EE200900049A EEP200900049A EEP200900049A EE200900049A EE 200900049 A EE200900049 A EE 200900049A EE P200900049 A EEP200900049 A EE P200900049A EE P200900049 A EEP200900049 A EE P200900049A EE 200900049 A EE200900049 A EE 200900049A
- Authority
- EE
- Estonia
- Prior art keywords
- stradiol
- ethin
- drospirenone
- contraceptive
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24095399P | 1999-08-31 | 1999-08-31 | |
EP99202826 | 1999-08-31 | ||
EEP200200110A EE05128B1 (en) | 1999-08-31 | 2000-08-31 | Pharmaceutical Composition and Preparation Containing Drospirenone and Ethinyl Stradiol, and the Use of Combinations thereof for the Preparation of a Pharmaceutical Composition |
Publications (2)
Publication Number | Publication Date |
---|---|
EE200900049A true EE200900049A (en) | 2009-10-15 |
EE05317B1 EE05317B1 (en) | 2010-08-16 |
Family
ID=26153358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200900049A EE05317B1 (en) | 1999-08-31 | 2000-08-31 | Ethin 1 "Pharmaceutical Composition Containing Stradiol and Drospirenone for Use as a Contraceptive |
Country Status (11)
Country | Link |
---|---|
CN (1) | CN1223350C (en) |
BG (2) | BG109749A (en) |
CA (1) | CA2382426C (en) |
EE (1) | EE05317B1 (en) |
HR (1) | HRP20020258B1 (en) |
IL (2) | IL197396A (en) |
MX (1) | MXPA02002043A (en) |
NO (3) | NO327588B3 (en) |
RU (4) | RU2449796C9 (en) |
SK (1) | SK287634B6 (en) |
UA (1) | UA81387C2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1625849A1 (en) * | 2004-08-09 | 2006-02-15 | Liconsa, Liberacion Controlada de Sustancias Activas, S.A. | Pharmaceutical composition comprising drospirenone and ethynylestradiol |
CN101489563A (en) * | 2006-07-06 | 2009-07-22 | 拜耳先灵医药股份有限公司 | Pharmaceutical preparations for contraception and for preventing the risk of congenital malformations |
EP3936133A1 (en) | 2011-11-23 | 2022-01-12 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
RU2618471C2 (en) * | 2012-12-03 | 2017-05-03 | Закрытое Акционерное Общество "Вертекс" | Oral pharmaceutical composition of diuretics and ace inhibitor in micronized form, drug and its application |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
CN108606963B (en) * | 2017-12-27 | 2021-05-18 | 上海长海医院 | Compound contraceptive patch containing drospirenone and estrogen, preparation method and application |
CN111529482A (en) * | 2020-05-20 | 2020-08-14 | 祝培 | Testosterone undecanoate sustained-release implant and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2652761C2 (en) * | 1976-11-16 | 1985-11-21 | Schering AG, 1000 Berlin und 4709 Bergkamen | 15,16-methylene-spirolactones, processes for their preparation and pharmaceuticals containing them |
DE4344462C2 (en) * | 1993-12-22 | 1996-02-01 | Schering Ag | Composition for contraception |
DE4411585A1 (en) * | 1994-03-30 | 1995-10-05 | Schering Ag | Combined pharmaceutical preparation for hormonal contraception |
ES2223081T3 (en) * | 1996-07-26 | 2005-02-16 | Wyeth | MONOFASTIC ORAL ANTICONCEPTIVE METHOD AND KIT THAT INCLUDES A COMBINATION OF PROGESTINE AND STROGEN. |
-
2000
- 2000-08-31 EE EEP200900049A patent/EE05317B1/en not_active IP Right Cessation
- 2000-08-31 RU RU2002107987/15A patent/RU2449796C9/en not_active IP Right Cessation
- 2000-08-31 UA UA2002032519A patent/UA81387C2/en unknown
- 2000-08-31 CA CA002382426A patent/CA2382426C/en not_active Expired - Lifetime
- 2000-08-31 CN CNB008150540A patent/CN1223350C/en not_active Expired - Lifetime
- 2000-08-31 MX MXPA02002043A patent/MXPA02002043A/en active IP Right Grant
- 2000-08-31 RU RU2002107987/15K patent/RU2269342C2/en not_active IP Right Cessation
- 2000-08-31 SK SK257-2002A patent/SK287634B6/en not_active IP Right Cessation
-
2002
- 2002-03-20 BG BG109749A patent/BG109749A/en unknown
- 2002-03-20 BG BG106533A patent/BG65204B1/en unknown
- 2002-03-27 HR HR20020258A patent/HRP20020258B1/en not_active IP Right Cessation
-
2005
- 2005-10-14 RU RU2005131868/15A patent/RU2396082C2/en active
-
2008
- 2008-09-08 NO NO20083854A patent/NO327588B3/en not_active IP Right Cessation
-
2009
- 2009-03-04 IL IL197396A patent/IL197396A/en active IP Right Grant
- 2009-05-07 NO NO20091809A patent/NO20091809L/en not_active Application Discontinuation
- 2009-08-19 IL IL200482A patent/IL200482A0/en unknown
-
2010
- 2010-02-26 NO NO2010004C patent/NO2010004I1/en unknown
- 2010-04-14 RU RU2010114825/15A patent/RU2482853C2/en active
Also Published As
Publication number | Publication date |
---|---|
IL197396A (en) | 2010-04-29 |
NO327588B1 (en) | 2009-08-31 |
RU2005131868A (en) | 2007-04-20 |
RU2010114825A (en) | 2011-10-20 |
MXPA02002043A (en) | 2003-08-20 |
NO20083854L (en) | 2002-04-26 |
BG109749A (en) | 2008-06-30 |
CA2382426C (en) | 2006-02-28 |
BG106533A (en) | 2002-10-31 |
CA2382426A1 (en) | 2001-03-08 |
NO20091809L (en) | 2002-04-26 |
CN1223350C (en) | 2005-10-19 |
RU2482853C2 (en) | 2013-05-27 |
SK287634B6 (en) | 2011-04-05 |
HRP20020258B1 (en) | 2007-05-31 |
CN1407895A (en) | 2003-04-02 |
RU2269342C2 (en) | 2006-02-10 |
EE05317B1 (en) | 2010-08-16 |
NO2010004I1 (en) | 2010-03-22 |
RU2269342C9 (en) | 2007-10-27 |
UA81387C2 (en) | 2008-01-10 |
RU2449796C9 (en) | 2007-10-27 |
SK2572002A3 (en) | 2002-11-06 |
NO327588B3 (en) | 2011-05-16 |
RU2396082C2 (en) | 2010-08-10 |
BG65204B1 (en) | 2007-07-31 |
HRP20020258A2 (en) | 2005-02-28 |
IL200482A0 (en) | 2011-07-31 |
RU2449796C2 (en) | 2006-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0203939A3 (en) | Pharmaceutical compounds and compositions containing them and their use | |
HUP0202495A3 (en) | Stable medicinal compositions for oral use | |
HUP0203971A3 (en) | Imidazoimidazoles and triazoles as anti-inflammatory agents and pharmaceutical compositions containing them and their use | |
HUP0200548A2 (en) | Pharmaceutical compositions and their use | |
HUP0200879A3 (en) | Pharmaceutical composition for dermal use | |
HUP0203588A3 (en) | Analgesic pharmaceutical compositions and their use | |
IL136827A0 (en) | Oral pharmaceutical extended release dosage form | |
HUP0200714A3 (en) | Pharmaceutical compounds, pharmaceutical compositions containing them and their use | |
HUP0003929A3 (en) | Piperazine derivatives and their use for producing pharmaceutical compositions as anti-inflammatory agents and pharmaceutical compositions containing them | |
HUP0200831A3 (en) | Novel pharmaceutical composition containing amoxycillin and its use | |
HUP9900605A3 (en) | Lipopolyamines as transfection agents, preparation and use thereof and pharmaceutical compositions containing them | |
HUP0203378A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
HUP0103406A3 (en) | 1h-imidazopyridine derivatives and pharmaceutical compositions thereof | |
HUP0100178A3 (en) | Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof | |
HUP0102990A3 (en) | Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof | |
MA26507A1 (en) | AEROSOL PHARMACEUTICAL COMPOSITIONS | |
HUP0103008A3 (en) | Phenoxyacetic acid derivatives and medicinal compositions containing the same | |
IL133097A0 (en) | Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof | |
HU9800147D0 (en) | Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them | |
HUP0103203A3 (en) | Azaadamantane derivatives and pharmaceutical compositions thereof | |
HUP0200747A2 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
HUP0104852A3 (en) | Oktahydro-pyrido-pyrazine derivatives and pharmaceutical compositions containing the same and their use | |
EE05317B1 (en) | Ethin 1 "Pharmaceutical Composition Containing Stradiol and Drospirenone for Use as a Contraceptive | |
HUP0101733A3 (en) | Pharmaceutical compositions containing sulfonyl-dipeptides and their use | |
EE200100051A (en) | Use of (+) - norcisapride or a pharmaceutically acceptable salt thereof substantially free of the corresponding (-) - stereoisomer and pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB4A | Valid patent at the end of a year |
Effective date: 20101231 |
|
HC1A | Change of owner name | ||
MF4A | Right revoked following opposition or revocation | ||
TH4A | Reinstatement | ||
MF4A | Right revoked following opposition or revocation |
Effective date: 20000831 |